$2,699.00
In Stock
Enhertu
HER2-positive breast cancer with metastases, or in the absence of surgical intervention in patients over 18 years of age.
Also indicated for the treatment of adults with metastatic gastric cancer: HER2-positive adenocarcinoma. Enherta is used if the patient has already undergone chemotherapy with trastuzumab (Herceptin) in the first line.
Active ingredient: trastuzumab
Storage temperature 2-8 degrees
Prescription drug
